DANIELLE JIVIDEN: Open Payments
NPI 1033889175 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,699 in 80 payments from 13 companies in 2025. Trend: 2023 $98 · 2024 $828 · 2025 $1,699
Food & beverage: $1,699
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $447 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $244 |
| Janssen Biotech, Inc. | 10 | $234 |
| Madrigal Pharmaceuticals | 5 | $158 |
| GENZYME CORPORATION | 5 | $151 |
| Phathom Pharmaceuticals, Inc. | 7 | $123 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $90 |
| Biocon Biologics Inc | 3 | $70 |
| PFIZER INC. | 3 | $68 |
| Aimmune Therapeutics, Inc. | 3 | $46 |
Products named: TREMFYA, ENTYVIO, DUPIXENT, RINVOQ, REZDIFFRA, SKYRIZI, VOQUEZNA, XIFAXAN.
Industry payments across FL — which companies pay providers there.
